Latest News

Technology-focused corporate venturing deals with a decade of boom, bust and back to growth again.

Pat Hyek, global technology industry leader at Ernst & Young, analyses the future for technology.

Observations from studying large multinational companies by
Johann Jakob Napp, Centre for Technology Management, University of Cambridge

Steven Kaplan, Neubauer family professor of entrepreneurship and finance, and faculty director of the Polsky Entrepreneurship Center, at the University of Chicago's Booth School of Business, and Josh Lerner, Jacob H Schiff professor of investment banking at Harvard Business School, analysis the data behind venture capital's prospects and finds the future brighter than pessimists expect.

Global Corporate Venturing round-up of last month's deals involving a corporate venturing unit across all sectors.

Global Corporate Venturing identifies the 50 most influential corporate venturing divisions of information and communication technology equipment and services companies.

Case study of Bicycle Therapeutics, which has two venture capital firms and two corporate venturing divisions in its first round of funding.

Healthcare venture capital firms reap rewards when working with corporate venturing peers.

Merck Serono's decision to set up a Ventures team has led to 400 opportunities in its first nine months and two deals.

Profile of Eli Lilly's corporate venturing divisions reveals their evolution since the 1980s and recent transformation to an independent fund structure able to act globally.

Case study of CardioDx reveals direction of General Electric's $250m healthcare corporate venturing fund set up late last year.